9 completed. 9 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 9 |
| Phase 3 | 1 | Completed 1 |
Follow Cancer Cachexia: new trials by email Literature Review of Cancer Cachexia trials Research Report on Cancer Cachexia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Head and Neck Cancer Curcumin, Placebo - Cancer Cachexia, Head and Neck Cancer | Phase 2 | Completed | Phramongkutklao College of Medicine and Hospital | 20 | 2020-02-13 | 2023-03-28 |
| Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia Macimorelin, Placebo - Cancer Cachexia | Phase 2 | Completed | Garcia, Jose M., MD, PhD | 15 | 2012-05-01 | 2024-03-20 |
| Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy BioMega SDA®, Sunflower oil high oleic - Cancer Cachexia, Head and Neck Cancer | Phase 2 / Phase 3 | Completed | General Hospital Groeninge | 91 | 2012-04-01 | 2015-03-10 |
| A Clinical Study With MT-102 in Subjects With Cancer Cachexia MT-102 - Cancer Cachexia | Phase 2 | Completed | Akamis Bio | 87 | 2011-04-01 | 2014-09-10 |
| Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia RC-1291, placebo - Cancer Cachexia | Phase 2 | Completed | Helsinn Therapeutics (U.S.), Inc | 51 | 2006-09-01 | 2013-09-02 |
| Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia. RC-1291 HCl, Placebo - Cancer Cachexia | Phase 2 | Completed | Helsinn Therapeutics (U.S.), Inc | 2005-11-01 | 2013-09-02 | |
| Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss RC-1291 HCl - Cancer Cachexia | Phase 2 | Completed | Helsinn Therapeutics (U.S.), Inc | 80 | 2005-06-01 | 2013-09-02 |
| A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss Fish oil supplement - Cancer, Cancer Cachexia | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 25 | 2004-06-01 | 2019-01-18 |
| Parenteral Nutrition Support for Patients With Pancreatic Cancer parenteral nutrition - Cancer Cachexia, Pancreatic Cancer | Phase 2 | Completed | CONKO-Studiengruppe | 32 | 2002-01-01 | 2009-06-12 |
Cachexia (2) · Head and Neck Neoplasms (2) · Neoplasms (2) · Weight Loss (2) · Anorexia (1) · Arthritis, Rheumatoid (1) · Hyperphagia (1) · Pancreatic Neoplasms (1) · Pulmonary Disease, Chronic Obstructive (1)
Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Body Weight (4) · Body Weight Changes (4) · Neoplasms (3) · Neoplasms by Site (3) · Signs and Symptoms, Digestive (2) · Thinness (2) · Weight Loss (2) · Arthritis (1) · Autoimmune Diseases (1) · Chronic Disease (1) · Connective Tissue Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1)
Curcumin (1) · Parenteral Nutrition (1) · RC-1291 (1) · macimorelin (1)
Helsinn Therapeutics (U.S.), Inc (3) · Akamis Bio (1) · CONKO-Studiengruppe (1) · Garcia, Jose M., MD, PhD (1) · General Hospital Groeninge (1) · Phramongkutklao College of Medicine and Hospital (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (5) · Germany (2) · Belgium (1) · India (1) · Malaysia (1) · Thailand (1)
William Polvino, MD (3) · Adrian S. Dobs, MD, MHS (1) · Jose M Garcia, MD, PhD (1) · Philip R Debruyne, MD PhD (1) · Tawasapon Thambamroong, MD (1) · Tom Boterberg, MD PhD (1)
PMID 25524795, PMID 10444409, PMID 11323096, PMID 11712783, PMID 12676044, PMID 17509812, PMID 17942826, PMID 18628464, PMID 19393114, PMID 20214798, PMID 21296615, PMID 21565893, PMID 21810420, PMID 23530101, PMID 24614693, PMID 24648302, PMID 25293388, PMID 27888116, PMID 29575771, PMID 2988769, PMID 35694030, PMID 36860137, PMID 7424938
P50AT000437 (1)